Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
Clinical trial NCT00542451 · COMPLETED
Trial details
- NCT number
- NCT00542451
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2014-04-21
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.